News from karo pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

10:14 GMT Further Clarification Regarding the ROR-gamma Project

On November 5, 2019, Karo Pharma Aktiebolag ("Karo Pharma") issued a press release regarding the Pfizer collaboration and license agreement related...


15 Nov, 2019, 07:11 GMT Karo Pharma - Interim Report January - September 2019

JULY - SEPTEMBER Net sales amounted to MSEK 443.7 (395.3). This corresponds to an increase of 12% for the period, of which the acquired operations...


05 Nov, 2019, 07:49 GMT Termination of Project Regarding ROR-gamma

In December 2011, Karo Pharma Aktiebolag ("Karo Pharma") entered into a research collaboration and license agreement with Pfizer, with the purpose of ...


31 Oct, 2019, 16:12 GMT New Number of Shares and Votes in Karo Pharma

As previously announced, Karo Pharma Aktiebolag ("Karo Pharma") has completed a rights issue of 60,700,422 shares, with the purpose of repaying a...


08 Oct, 2019, 12:21 BST Karo Pharma Postpones Publication of the Interim Report for the Period January - September 2019

The board of directors of Karo Pharma Aktiebolag ("Karo Pharma") has resolved to postpone the publication of the interim report for the period...


20 Sep, 2019, 15:15 BST Extraordinary General Meeting in Karo Pharma Aktiebolag on 20 September 2019

At today's extraordinary general meeting in Karo Pharma, the following resolution was passed. The general meeting resolved, in accordance with the...


19 Sep, 2019, 16:51 BST Karo Pharma's Planned Rights Issue is Intended to Amount to Approximately SEK 2 Billion

As communicated on 12 September 2019, Karo Pharma Aktiebolag ("Karo Pharma") has completed its acquisition of Trimb Holding AB. The acquisition was...


12 Sep, 2019, 16:21 BST Karo Pharma Completes the Acquisition of Trimb and Carries out Management Changes

Karo Pharma Aktiebolag ("Karo Pharma") today announces that the acquisition of all the shares of Trimb Holding AB ("Trimb") from Avista Capital...


04 Sep, 2019, 13:21 BST The Swedish Competition Authority Approves Karo Pharma's Acquisition of Trimb and Karo Pharma Continues the Company's Efforts Elated to Internalisation of Sales and Marketing

Karo Pharma Aktiebolag (the "Company" or "Karo Pharma") today announces that the acquisition of all the shares of Trimb Holding AB ("Trimb") from...


28 Aug, 2019, 12:17 BST NOTICE OF EXTRAORDINARY GENERAL MEETING IN KARO PHARMA AKTIEBOLAG

The shareholders of Karo Pharma Aktiebolag, reg. no 556309-3359, are given notice of an Extraordinary General Meeting, to be held on Friday 20...


14 Aug, 2019, 07:40 BST Jon Johnsson Appointed New CFO of Karo Pharma

Karo Pharma Aktiebolag (publ) ("Karo Pharma") has appointed Jon Johnsson as the new CFO of Karo Pharma, replacing Mats-Olof Wallin, who will retire...


19 Jul, 2019, 15:32 BST Clarification of the Statement in the Interim Report Published 19 July 2019 Regarding the Rights Issue with Pre-emptive Rights

Karo Pharma Aktiebolag ("Karo Pharma") today published its interim report for the period January - June 2019. On page 2 of the Swedish language...


19 Jul, 2019, 07:21 BST Karo Pharma: Interim Report January - June 2019

The Period And The Second Quarter Net sales amounted to MSEK 808.2 (756.5), whereof the second quarter MSEK 387.4 (489.4). This corresponds to an...


21 Jun, 2019, 03:54 BST Karo Pharma Acquires Trimb for MSEK 3,400 and Intends to Carry out a Rights Issue of Approximately MSEK 1,500

Karo Pharma AB (publ) (the "Company" or "Karo Pharma") has today acquired all the shares of Trimb Holding AB ("Trimb") from Avista Capital Partners...


16 May, 2019, 16:45 BST Annual General Meeting 2019 in Karo Pharma Aktiebolag

The annual general meeting resolved to adopt the income statement and balance sheet for the group and the parent company. The annual general meeting...


26 Apr, 2019, 08:31 BST Karo Pharma: Interim Report The First Quarter 2019

Net sales amounted to MSEK 420.8 (267.1). This corresponds to an increase of 58%. The growth is attributable to products acquired during the period....


16 Apr, 2019, 14:26 BST Notice of Annual General Meeting in Karo Pharma Aktiebolag

The shareholders of Karo Pharma Aktiebolag, reg. no. 556309-3359, are given notice of the annual general meeting to be held at 14:00 CET on 16 May...


09 Apr, 2019, 07:42 BST Karo Pharma Publishes the 2018 Annual Report

Karo Pharma publishes its annual report for 2018. Today, on 9 April 2019, Karo Pharma is publishing its annual report for 2018 on the company's...


09 Apr, 2019, 07:10 BST New Date for the Annual General Meeting of Karo Pharma

New date for the annual general meeting 2019 of Karo Pharma. The board of directors of Karo Pharma has resolved to postpone the annual general...


03 Apr, 2019, 07:24 BST Christoffer Lorenzen Appointed CEO of Karo Pharma; Peter Blom Resigning

The Board of Karo Pharma Aktiebolag (publ) ("Karo Pharma") has appointed Christoffer Lorenzen as the new CEO of Karo Pharma, replacing Peter Blom....


14 Feb, 2019, 07:56 GMT YEAR-END REPORT 2018

HUDDINGE, Sweden, Feb. 14, 2019 FULL YEAR AND THE FOURTH QUARTER Net sales amounted to MSEK 1,615.1 (657.6), of which the fourth quarter amounted to...


11 Feb, 2019, 08:26 GMT Karo Intressenter's Proposals Ahead of the Extraordinary General Meeting in Karo Pharma on 14 February 2019

EQT VIII[1] through Karo Intressenter AB ("Karo Intressenter") proposes, ahead of the Extraordinary General Meeting in Karo Pharma Aktiebolag ("Karo...


02 Jan, 2019, 07:44 GMT Statement by the Board of Directors of Karo Pharma Aktiebolag in Relation to the Increased Public Offer From EQT VIII, Through Karo Intressenter AB

The Board of Directors of Karo Pharma Aktiebolag has concluded to unanimously recommend that the shareholders of Karo Pharma Aktiebolag accept the...


03 Dec, 2018, 03:01 GMT Anders Lönner, Chairman of the Board Karo Pharma AB, has Suddenly Passed Away

"It is with great regret and sadness we announce this very tragic and unexpected information", says the Board of Directors, Karo Pharma. "Anders...


16 Nov, 2018, 07:11 GMT Karo Pharma: Marketing Territory for Viruseptin® Extended to Include Denmark

Karo Pharma AB extends the marketing territory for Viruseptin® to include Denmark and have with this the marketing rights across the Nordic countries....